Catalyst overview
Research summary
This catalyst tracks a Phase 2 data readout for SPY003 in Ulcerative colitis. The expected timing is based on the latest available company guidance and may change.
03/16/26:- SKYLINE UC platform enrolling ahead of schedule; Part A readouts begin Q2 2026. 04/13/26:- SKYLINE Part A induction data expected Q3 2026. Part B induction data remains on track for 2027. 05/05/26:- SPY003 Phase 1 safety and PK data supportive; ECCO 2026 results highlighted. SKYLINE Part A induction data Q3 2026. 06/03/26:- SKYLINE Part A now fully enrolled. Part A induction data remains expected in Q3 2026. 08/04/26:- SKYLINE SPY003 Part A data expected September 2026; Part B data 2027.
Verification
Confirm timing and program details against the company announcement or filing.